What is Nymox Pharmaceutical Corporation?
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 4.76M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.